PROCEDURES FOR HANDLING OOS RESULTS



Similar documents
Guidance for Industry

Conducting Effective OOS or OOT Investigations for Unexpected Results from the BET Assay

ASSURING THE QUALITY OF TEST RESULTS

1 Quality Assurance and Quality Control Project Plan

APPENDIX 7-B SUGGESTED OUTLINE OF A QUALITY ASSURANCE PROJECT PLAN

Checklist. Standard for Medical Laboratory

Design of Experiments for Analytical Method Development and Validation

Deviation and Out of Specification Handling

Medical Cannabis Laboratory Approval Program

Content Sheet 7-1: Overview of Quality Control for Quantitative Tests

APPENDIX N. Data Validation Using Data Descriptors

Data Integrity & Technical Ethics

XV.Quality Assurance in the Blood Bank

American Association for Laboratory Accreditation

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

MIDLAND AREA SOIL SAMPLING MIDLAND, MICHIGAN

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

Control Charts and Trend Analysis for ISO Speakers: New York State Food Laboratory s Quality Assurance Team

How to Verify Performance Specifications

Data Quality. Tips for getting it, keeping it, proving it! Central Coast Ambient Monitoring Program

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence

AN AUDIT QUESTIONNAIRE THAT EXAMINES SPECIFICALLY THE MANAGEMENT OF TECHNICAL ACTIVITIES CLAUSES IN ISO 15189

Calculation of Risk Factor Using the Excel spreadsheet Calculation of Risk Factor.xls

Dedicated and calibrated pipettes can reduce variability. The Most Expensive Test is a Retest By Ruth Noe, UK and Ireland Sales Manager

Using and Maintaining Documents and Records. Finding the information when you need it

Analytical Test Method Validation Report Template

GMP Training Course Quality Control October Lesley Graham Senior Inspector (UK)

How Far is too Far? Statistical Outlier Detection

URINE COLLECTION, PREPARATION AND HANDLING

Haulsey Engineering, Inc. Quality Management System (QMS) Table of Contents

Individualized Quality Control Plan

Ecology Quality Assurance Glossary

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

To avoid potential inspection

Procedure: Quality Assurance Policy Version 5 Quality Assessment Policy Version 3

Technical Guidance Manual for the Implementation of the Hawai`i State Contingency Plan. Interim Final SECTION 10

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

LAB ID and/or LABORATORY NAME: ASSESSOR NAME: CONTINUOUS RADON MONITOR (CRM) by Proportional Counting. Method Number: ELAP method code 7037

Calibration Verification

USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

Evaluating Laboratory Data. Tom Frick Environmental Assessment Section Bureau of Laboratories

Electronic Raw Data and the Use of Electronic Laboratory Notebooks

CHAPTER ONE TABLE OF CONTENTS 1.0 INTRODUCTION... 1

Working Copy - 1,- / t&,1 r. Responsibilities of the Laboratory Quality Assurance Officer. EffectiveDate: 7/ltl/ l'rritials: tuwt

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

The Importance of Following the PROTOCOL in Clinical Trials

Pharmaceutical Wholesaler Site Inspection Checklist

Implementing New USP Chapters for Analytical Method Validation

Cold Agglutination Titer detecting Cold Reacting Antibodies

Thermo Scientific Dionex Chromeleon 7 Chromatography Data System Software

Assay Qualification Template for Host Cell Protein ELISA

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

General. What is a laboratory test? What is a waived test?

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT

Review and Approve Results in Empower Data, Meta Data and Audit Trails

Microbiology and Auditing. Don Singer

State Meat and Poultry Inspection (MPI) Program Laboratory Quality Management System Checklist

The BlazeLIMS Family of Products Functional Specs V5.5

Prepublication Requirements

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

UNCONTROLLED COPY FOR REFERENCE ONLY

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Content Sheet 16-1: Introduction to Documents & Records

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Validating Methods using Waters Empower TM 2 Method. Validation. Manager

White Paper: Evaluation of Petitioner Concerns About Data Falsification and/or Data Invalidation in RFP Building 123 Based on Worker Allegations

Audit Report in the framework of the APIC Audit Programme

AS9100 Quality Manual

LAP Audioconference How to Prepare and Comply with Your Quality Management Plan* February 18, 2009

Final. Internal Audit Report. Creditors System

Process Validation: Practical Aspects of the New FDA Guidance

STABILITY TESTING OF ACTIVE SUBSTANCES AND PHARMACEUTICAL PRODUCTS

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

White paper: The 10 Golden Rules of GMP

Packaging Validation Protocol (Reference: SOP )

The Role of the Laboratory in Clinical Trials. Basma Elgamal, M.D. Professor of Clinical Pathology National Cancer Institute, Cairo University

LabGuide 71. Incident Management: Developing a Plan

Good Research Practice

US Environmental Protection Agency Office of Pesticide Programs

United States Department of Agriculture Agricultural Marketing Service, Science & Technology Microbiological Data Program

The FDA recently announced a significant

PERFORMANCE EVALUATION AUDIT CHECKLIST EXAMPLE. EIIP Volume VI

ORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT

Standard Operating Procedure Title: Manufacturing Rework Procedure

OOS investigations in a GMP environment

Content Sheet 3-1: Equipment Management Overview

New changes to cleanroom & clean air device classifications: ISO & 2

Incident Management: Developing a Plan

QUALITY ASSURANCE / QUALITY CONTROL POLICY BREG SOIL AND WATER QUALITY LABORATORY UNIVERSITY OF DELAWARE

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING

FOOD FOR THOUGHT Topical Insights from our Subject Matter Experts UNDERSTANDING WHAT IS NEEDED TO PRODUCE QUALITY DATA

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

IQCP GUIDELINES and TEMPLATE FOR GETTING STARTED

A Roadmap for Competency Assessment ASCLS-NJ Spring Seminar April 24, 2014

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager

HPLC Analysis of Acetaminophen Tablets with Waters Alliance and Agilent Supplies

Samples RMN Analytical Report ( ) GC/FID Analysis (RM01) Nicotine Purity

Transcription:

SOP # A-195--0100 STANDARD OPERATING PROCEDURES Page: 1 of 6. PROCEDURES FOR HANDLING OOS RESULTS 1. PURPOSE The purpose of this Standard Operation Procedure is to establish a procedure for the routine handling of out-of-specification (OOS) laboratory results The investigation or failure investigation should where ever possible identify the cause of the OOS and evaluate its impact. 2. RESPONSIBILITY Each Analyst or Researcher is responsible for the immediate analytical review of OOS results in cooperation with the laboratory head of supervisor/delegate. All solutions and standards must be preserved and properly stored. The laboratory head of supervisor is responsible for the final decision as to the disposition and use of the result. 3. FREQUENCY Immediately afterwards (where possible) or within 1 to 2 days of each completed analytical test (after being checked, audited and reviewed by the supervisor). 4. PROCEDURE [a]. Analysts may classify Out-of-Specification Test Results (OOS) as reversible or as non-reversible due to either a :- genuine laboratory error or sampling error Non-reversible classification may cover:- manufacturing or processing errors (including manufacturing operator error) [b.] Investigation for Genuine Laboratory Analytical Error. Analysts must investigate for laboratory errors which can occur when analysts make analytical mistakes. Check if samples were incorrectly prepared, diluted, injected or stored at inappropriate environmental temperatures or that containers not properly closed or possibly not sampled in the correct designated sampling container. [e.] Suspected laboratory error must be investigated and if a genuine error is found, then the OOS result must immediately be invalidated. The OOS result must be disregarded (after appropriate recording and filing). [c]. Each Analyst shall review for completeness the entire test procedure, equipment / calibration and calculation used in obtaining the test result using the attached guideline checklists.

PROCEDURES FOR HANDLING OOS RESULTS Page: 2 of 6 [d]. The supervisor shall review and discuss in depth with the analyst, the execution of the entire analytical testing procedure, equipment and calculation used. [e.] Once the nature of the OOS has been identified - as an laboratory error - a repeat test must be performed and the initial test totally discarded as a reversible laboratory error. (since the initial test result was proven invalid) [f.] The analytical or analyst error must be thoroughly documented and properly invalidated - with written reasons, together with the supervisor and analyst signatures and date of the invalidation process. INCONCLUSIVE ERRORS RETEST [g.] An inconclusive error is an OOS where the 'supervisor-analyst investigation' did not draw a firm conclusion and the reason for the error was not clearly identified. [h.] Retest with new aliquot (replicates, if required) from the same sample, if the sampling procedure was proven OK by investigation. [i.] If the sampling procedure is found to be in error, then re-sample the target material is undertaken and a new duplicate analysis is performed. DECISION TREE 5. LIMITATION [j.] An overview of Out-of-Specification Results procedures is provided by a decision tree flowchart. The decision tree provides a logical set of procedural steps in order to standardize the investigative procedure for all analysts when performing an OOS investigation. [f.] Re-sampling the material for a new representative sample should take place only when the original procedure was found to be clearly non-representative of the whole. 6. DOCUMENTATION [k.] Out-of-specification (OOS) Test Results Report or failure investigation Test Result Report is prepared and filed. [End of Document] 1234567❶❷❸

SOP # A-195--0100 C HECKLIST OUT-of-SPECIFICATION RESULTS Averaging passing and OOS Test Results together is not permitted as it conceals the full analytical picture IDENTIFYING OOS TEST RESULTS 1. Does the firms have a clear SOP spelling out the procedure and investigations required when ever an OOS result is obtained? 2. Are all firm's 'rejected batch' OOS results investigated as well? 3. Are the previous (or related) batches associated with the failed batch specification reviewed and the overall impact (on quality) evaluated? 4. Are written investigations undertaken and then follow-up procedures recommended in writing? 5. Are the investigations performed in a timely manner and follow a defensible scientific logic (see attached Decision Tree)? 6. Does the companies 'Investigation SOP' include the three key tenants i.e. TO INVESTIGATE - TO CONCLUDE - TO FOLLOW-UP? 7. Have the laboratory analysts been instructed to keep the original 'suspect test solutions' for possible reanalysis (Ref. Decision Tree)? 8. When an OOS has been detected does the initial review, before the investigation, check for instrument or system suitability malfunction, faulty reagents, calculation, documentation or transcribing errors? 9. If no clear analytical errors are detected in a 'suspect result' does a comprehensive 'failure investigation' ALWAYS follow? 10. Where malfunctions are identified and detected are all prior 'suspect data' evaluated and reviewed for a possible related (or similar) errors? 11. Are analytical failures tracked back to their original point of failure? 12. When a faulty lab procedure is detected, is the analytical test procedure immediately terminated (as a matter of routine)? 13. Have the analysts been trained to immediately report to their supervisors an obvious error or an analytical fault? 14. Are obvious errors (spilling, incorrect dilution, injection volume etc.) documented in the lab book and a brand new test restarted? Page: 3 of 6

SOP # A-195--0100 C HECKLIST OUT-of-SPECIFICATION RESULTS failure investigations are conducted to determine what caused the unexpected OOS result INVESTIGATING OOS TEST RESULTS 15. Does the supervisor's 'initial assessment' follow a written in-house 'SOP procedure '? 16. Are the retained 'suspect' sample preparations examined during the 'initial assessment' and then retested promptly on initiating the 'failure investigation'? 17. Where a clear error is identified, is the result immediately invalidated? 18. Where clear error is T identified, is a failure investigation conducted immediately? 19. Is the firm's full scale failure investigation fully predefined in writing? 20. Does the firm's own QC Unit perform the 'full scale failure investigation'? 21. Does the general review include a list of related batches which may be impacted? 22. Does the full scale failure investigation include the production side and the laboratory side? 23. Does the laboratory protocol include the two key steps - retesting the original sample and testing a new sample from the batch lot? 24. Retesting the original sample with a new analyst, is generally the first step after the 'initial assessment' is completed? 25. Are the number of re-tests (usually duplicates) specified and not exceeded? Averaging 'original suspect' and retest results is forbidden. 26. When improperly prepared samples are proven as faulty, then the original test results may be immediately invalidated? 27. The firm may re-sample when the investigation highlights that the original sample was unrepresentative? 28. Where the investigation concludes that the sampling method is in error a new sampling method must be developed and qualified? 29. To prove the original aliquot is faulty, the analyst prepares two additional aliquots and compares the three sets of results? Page: 4 of 6

SOP # A-195--0100 C HECKLIST OUT-of-SPECIFICATION RESULTS Batches must be formulated with the intent to provide 100% of the labeled amount ' AVERAGING IN OOS RESULTS 30. Averaging results from a standard solution or a test aliquot is acceptable (i.e. averaging replicate results). 31. Averaging results from microbial count plates are quite acceptable. 32. Averaging a set of results, where some are OOS is not acceptable. 33. Hiding an OOS result in any average is not acceptable. 34. When the intent is to highlight variability within the product then averaging is not acceptable, but RSD (CV) values are generally reported to show statistical significance. 35. Replicate peak responses whether test or standard should be averages as one result. 36. Are analysts trained, so not to average passing and OOS results together in order to hide the failing results? 37. Composite assays, require only one assay result and are in fact average assay values, as opposed to individual content uniformity values. 38. OUTLIER USE IN OOS RESULTS 39. Where 'control' and 'specification' lower and upper limits are used in QC criteria an OUTLIER may be outside the control limits but inside the specifications limits? [i.e. an example of OUTLIER use.] 40. Analyst are trained not to assume OUTLIERS as testing errors but inherent variability in the sample. 41. The firm has an OUTLIERS SOP detailing the use of OUTLIER TESTS. 42. OUTLIERS are not permissible in Content Uniformity and Dissolution tests. 43. Where the intent is to measure the variability, OUTLIERS should not be used. Page: 5 of 6

OOS DETECTED DECISION (Follow Route 'A' (lab) and Route 'B' (mfg)) TREE. (IJGD Vol. #07 1998) PRODUCTION B Investigate A LABORATORY OOS Retest Clear laboratory error SPECIFICATION FAILURE (Evaluate Batch for Rejection) Same Sample Different Analyst Invalidate result & retest (DO T RETAIN RESULT) IF OOS Retain & Report result Suspect result Product PASSES Then RE-SAMPLE New representative specimen IF Don't Apply Outliers To: Content Uniformity Dissolution test Composite Assays OOS Out-of-Specification Decision Tree